Telomir Pharmaceuticals (TELO)
Develops an oral small-molecule candidate for advanced triple-negative breast cancer.
$1.13
At close+0.03 (+2.73%)
Something off on this page? Send us feedback.
Next report
Dec 2, 2026
estimated · in 90 days
EPS estimate
−$0.08
Revenue estimate
$500.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Dec '26
Reported−$0.10−$0.07−$0.17−$0.03−$0.06−$0.03−$0.79Pending
Estimate−$0.05−$0.10−$0.08−$0.07−$0.07−$0.07−$0.07−$0.08
Surprise−100.0%+30.0%−112.5%+57.1%+14.3%+57.1%−1,028.6%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Dec '26
Reported$18.8M——————Pending
Estimate———————$500.0K
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$0.08 | — | — |
| Aug 2026 | −$0.07 | −$0.79 | −1,028.6% |
| May 2026 | −$0.07 | −$0.03 | +57.1% |
| Mar 2026 | −$0.07 | −$0.06 | +14.3% |
| Nov 2025 | −$0.07 | −$0.03 | +57.1% |
The latest year is open to everyone — the 14 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2, 2026 | −$0.08 | — | — | $500.0K | — | — | — |
| Aug 13, 2026 | −$0.07 | −$0.79 | −1,028.6% | — | — | — | −5.4% |
| May 14, 2026 | −$0.07 | −$0.03 | +57.1% | — | — | — | −0.8% |
| Mar 17, 2026 | −$0.07 | −$0.06 | +14.3% | — | — | — | −5.9% |
| Nov 10, 2025 | −$0.07 | −$0.03 | +57.1% | — | — | — | +3.7% |
The latest year is open to everyone — the 14 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 14, 2025 | |||||||
| Feb 4, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 29, 2022 | |||||||
| Jun 29, 2022 | |||||||
| Mar 31, 2022 | |||||||